Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP1A2 | P05177 | 5/20 | 0.48 |
| ▸ | CYP2A6 | P11509 | 3/20 | 0.48 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.41 |
| ▸ | ADRA2A | P08913 | 1/20 | 0.41 |
| ▸ | ADRA2B | P18089 | 1/20 | 0.41 |
| ▸ | KDM4E | B2RXH2 | 3/20 | 0.40 |
| ▸ | MAPT | P10636 | 3/20 | 0.40 |
| ▸ | PLAU | P00749 | 1/20 | 0.39 |
| ▸ | SLC6A2 | P23975 | 1/20 | 0.38 |
| ▸ | SLC6A4 | P31645 | 1/20 | 0.38 |
| ▸ | SLC6A3 | Q01959 | 1/20 | 0.38 |
| ▸ | GAA | P10253 | 1/20 | 0.38 |
| ▸ | HTT | P42858 | 1/20 | 0.38 |
| ▸ | CD44 | P16070 | 1/20 | 0.36 |
| ▸ | CYP19A1 | P11511 | 1/20 | 0.36 |
| ▸ | TBXAS1 | P24557 | 1/20 | 0.36 |
| ▸ | NPC1 | O15118 | 1/20 | 0.35 |
| ▸ | PKM | P14618 | 1/20 | 0.35 |
| ▸ | RAB9A | P51151 | 1/20 | 0.35 |
| ▸ | ATM | Q13315 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30540104 | 1.00 | CYP1A2 (0.48) | CYP1A2CYP2A6ALDH1A1ADRA2AADRA2B | |
| SCHEMBL23430404 | 0.82 | CYP2A6 (0.44) | CYP1A2CYP2A6ALDH1A1MAPTHTT | |
| SCHEMBL5153625 | 0.75 | ADRA2A (0.56) | CYP2A6ALDH1A1ADRA2AADRA2BKDM4E | |
| SCHEMBL8114338 | 0.73 | ADRA2A (0.42) | CYP2A6ALDH1A1ADRA2AADRA2BKDM4E | |
| SCHEMBL3791942 | 0.71 | ADRA2A (0.44) | CYP2A6ALDH1A1ADRA2AADRA2BKDM4E | |
| SCHEMBL289078 | 0.71 | ADRA2A (0.41) | CYP2A6ALDH1A1ADRA2AADRA2BKDM4E | |
| SCHEMBL3794962 | 0.71 | ADRA2A (0.41) | ALDH1A1ADRA2AADRA2BKDM4EMAPT | |
| SCHEMBL911513 | 0.71 | ADRA2A (0.44) | CYP1A2CYP2A6ALDH1A1ADRA2AADRA2B | |
| SCHEMBL276421 | 0.71 | ADRA2A (0.41) | CYP2A6ADRA2AADRA2BKDM4EMAPT | |
| SCHEMBL24611290 | 0.71 | ADRA2A (0.41) | CYP2A6ALDH1A1ADRA2AADRA2BKDM4E |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 536 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-117534662-B | Norepinephrine chemiluminescence probe and preparation method and application thereof | 徐州医科大学 | 2024-11-29 | — | — | CN | claimed |
| CN-111695658-B | Anti-counterfeiting method based on PUF, PUF anti-counterfeiting label and preparation method thereof | 上海交通大学 | 2024-03-29 | — | — | CN | claimed |
| CN-117625236-A | Mo-MOF-based ionic nanofluid and preparation method and application thereof | 江苏大学 | 2024-03-01 | — | — | CN | claimed |
| CN-117534662-A | Norepinephrine chemiluminescence probe and preparation method and application thereof | 徐州医科大学 | 2024-02-09 | — | — | CN | claimed |
| CN-117263958-A | Fluorescent probe based on camphor derivative and preparation method and application thereof | 江苏食品药品职业技术学院 | 2023-12-22 | — | — | CN | claimed |
| CN-115286547-B | Method for synthesizing aryl benzyl thioether compound | 苏州大学 | 2023-11-03 | — | — | CN | claimed |
| CN-114602520-B | Double-immobilized phosphotungstate catalyst as well as preparation method and application thereof | 忻州师范学院 | 2023-08-08 | — | — | CN | claimed |
| CN-115305109-A | Temperature response type porous liquid extracting agent, and preparation method and application thereof | 江苏大学 | 2022-11-08 | — | — | CN | claimed |
| CN-114602520-A | Dual-immobilized phosphotungstate peroxide catalyst, and preparation method and application thereof | 忻州师范学院 | 2022-06-10 | — | — | CN | claimed |
| CN-108083393-A | The graphite electrode modified based on PbO-NiO-MgO and thiophene | 光合强化（北京）生物科技有限公司 | 2018-05-29 | — | — | CN | claimed |
| CN-103709163-B | Xanthine derivative, Preparation Method And The Use | 齐鲁制药有限公司 | 2016-12-21 | — | — | CN | claimed |
| CN-103289727-B | A kind of method of selective oxidation of sulfur containing compounds in particular | SINOPEC CORP. (CN) | 2015-07-29 | — | — | CN | claimed |
| US-20250114345-A1 | COMPOUNDS AND COMPOSITIONS AS CBP/P300 DEGRADERS AND USES THEREOF | ONCOPIA THERAPEUTICS, INC. D/B/A/ SK LIFE SCIENCE LABS | 2025-04-10 | — | — | US | disclosed |
| WO-2025049994-A1 | COMPOUNDS AND COMPOSITIONS AS CBP/P300 DEGRADERS AND USES THEREOF | ONCOPIA THERAPEUTICS, INC. D/B/A SK LIFE SCIENCE LABS (US) | 2025-03-06 | — | — | WO | disclosed |
| CN-118359474-A | Method for preparing electronic grade methylnaphthalene monomer by solvent extraction | 李守富 | 2024-07-19 | — | — | CN | disclosed |
| US-20240244858-A1 | ORGANOMETALLIC COMPOUND, ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME, AND ELECTRONIC APPARATUS INCLUDING THE ORGANIC LIGHT-EMITTING DEVICE | SAMSUNG DISPLAY CO., LTD. (KR) | 2024-07-18 | — | — | US | disclosed |
| EP-0894088-A1 | SUBSTITUTED SULFONIC ACID N- (AMINOIMINOMETHYL)PHENYLALKYL]-AZAHETEROCYCLAMIDE COMPOUNDS | RHONE-POULENC RORER PHARMACEUTICALS, INC. (US) | 1999-02-03 | — | — | EP | disclosed |
| WO-1998045272-A1 | TOPOISOMERASE INHIBITORS | LATROBE UNIVERSITY (AU) | 1998-10-15 | — | — | WO | disclosed |
| WO-1998024784-A1 | SUBSTITUTED SULFONIC ACID N-[(AMINOIMINOMETHYL)PHENYLALKYL]-AZAHETEROCYCLAMIDE COMPOUNDS | RHONE-POULENC RORER PHARMACEUTICALS INC. (US) | 1998-06-11 | — | — | WO | disclosed |
| US-5731315-A | Substituted sulfonic acid n- (aminoiminomethyl)phenylalkyl!-azaheterocyclamide compounds | RHONE-POULENC RORER PHARMACEUTICALS INC. (US) | 1998-03-24 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20250114345-A1 | COMPOUNDS AND COMPOSITIONS AS CBP/P300 DEGRADERS AND USES THEREOF | EP300, CREBBP, HDAC1 | CYP1A2 2388/4885CYP2A6 2204/4885ALDH1A1 1582/4885 |
| US-20240244858-A1 | ORGANOMETALLIC COMPOUND, ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME, AND ELECTRONIC APPARATUS INCLUDING THE ORGANIC LIGHT-EMITTING DEVICE | CRY1, CRY2, C1S | CYP1A2 181/4885CYP2A6 1318/4885ALDH1A1 1656/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.